Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Astrocytoma 8Glioblastoma 5Prostatic Neoplasms 4Neuroectodermal Tumors, Primitive 4Lymphoma, Non-Hodgkin 4Lung Neoplasms 3Recurrence 2Oligodendroglioma 2Neurocytoma 2Neoplasms 2Glioma 2Colonic Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Brain Neoplasms 2Waldenstrom Macroglobulinemia 1Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Stomach Neoplasms 1Somatostatinoma 1Small Intestine Cancer 1Small Cell Lung Carcinoma 1Sarcoma 1Salivary Gland Neoplasms 1Rhabdoid Tumor 1Pituitary Neoplasms 1Paranasal Sinus Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1

Interventions

pembrolizumab 6Mitotane 5Cisplatin 5cabozantinib 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Doxorubicin 3sodium thiosulfate 2relacorilant 2cixutumumab 2cemiplimab 2camrelizumab 2apatinib 2Radiotherapy 2Nivolumab 2Ipilimumab 2Etoposide 2Cytoreduction Surgical Procedures 2milademetan 1lenvatinib 1gossypol acetic acid 1dostarlimab 1cabazitaxel 1antineoplaston AS 2-1 1antineoplaston A10 1Vincristine 1Tamoxifen 1Suramin 1Sunitinib 1Sorafenib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Adrenocortical Carcinoma × antineoplaston AS 2-1 × Clear all
NCT00003453 2018-05-09

Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer

Burzynski Research Institute

Phase 2 Terminated
6 enrolled 6 charts
Endocrine

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡